Intrinsic caspase-8 activation mediates sensitization of erlotinib-resistant tumor cells to erlotinib/cell-cycle inhibitors combination treatment. [electronic resource]
Producer: 20130531Description: e415 p. digitalISSN:- 2041-4889
- Antineoplastic Combined Chemotherapy Protocols -- pharmacology
- Apoptosis -- drug effects
- Caspase 8 -- genetics
- Cell Cycle -- drug effects
- Cell Line, Tumor
- Cell Survival -- drug effects
- Cyclin A -- antagonists & inhibitors
- Cyclin-Dependent Kinase 2 -- antagonists & inhibitors
- Drug Resistance, Neoplasm -- drug effects
- Drug Therapy, Combination
- Erlotinib Hydrochloride
- Humans
- Neoplasms -- drug therapy
- Quinazolines -- pharmacology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.